London-based Boltz, an AI drug discovery startup spun out of MIT, announced a $110 million Series A on November 18, 2026, led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results